ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,251,328 | +15.8% | 241,005 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,670,506 | +2.7% | 241,005 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,574,104 | -70.1% | 241,005 | -54.6% | 0.00% | -66.7% |
| Q1 2022 | $11,945,058 | -28.9% | 530,420 | -41.8% | 0.00% | 0.0% |
| Q4 2021 | $16,809,000 | +38.0% | 911,046 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,181,000 | -43.4% | 911,046 | -21.6% | 0.00% | -40.0% |
| Q2 2021 | $21,506,000 | -9.0% | 1,161,866 | -26.2% | 0.01% | 0.0% |
| Q1 2021 | $23,633,000 | -22.7% | 1,573,957 | -25.7% | 0.01% | -28.6% |
| Q4 2020 | $30,580,000 | +77.4% | 2,117,727 | 0.0% | 0.01% | +40.0% |
| Q3 2020 | $17,238,000 | +48.9% | 2,117,727 | +23.9% | 0.01% | +66.7% |
| Q2 2020 | $11,574,000 | -3.8% | 1,709,529 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $12,035,000 | +68.4% | 1,709,529 | +134.7% | 0.00% | +100.0% |
| Q4 2019 | $7,148,000 | +3.3% | 728,299 | +15.6% | 0.00% | 0.0% |
| Q3 2019 | $6,918,000 | -5.6% | 630,059 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,328,000 | +21.9% | 630,059 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,010,000 | -69.6% | 630,059 | -69.3% | 0.00% | -71.4% |
| Q4 2018 | $19,775,000 | -32.3% | 2,051,345 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $29,231,000 | +18.7% | 2,051,345 | 0.0% | 0.01% | +12.5% |
| Q2 2018 | $24,616,000 | -6.7% | 2,051,345 | -3.9% | 0.01% | -20.0% |
| Q1 2018 | $26,373,000 | -26.0% | 2,135,449 | -12.9% | 0.01% | -23.1% |
| Q4 2017 | $35,661,000 | +29.6% | 2,450,888 | +26.8% | 0.01% | +30.0% |
| Q3 2017 | $27,507,000 | +5.4% | 1,933,024 | -5.5% | 0.01% | 0.0% |
| Q2 2017 | $26,110,000 | -35.4% | 2,046,231 | -35.8% | 0.01% | -41.2% |
| Q1 2017 | $40,441,000 | +39.5% | 3,189,372 | +12.3% | 0.02% | +30.8% |
| Q4 2016 | $28,999,000 | +21.7% | 2,840,246 | +49.9% | 0.01% | +18.2% |
| Q3 2016 | $23,827,000 | +4.3% | 1,894,191 | +5.3% | 0.01% | 0.0% |
| Q2 2016 | $22,837,000 | +3.4% | 1,798,177 | +7.6% | 0.01% | 0.0% |
| Q1 2016 | $22,077,000 | -14.1% | 1,671,199 | 0.0% | 0.01% | -15.4% |
| Q4 2015 | $25,703,000 | +62.0% | 1,671,199 | +30.6% | 0.01% | +62.5% |
| Q3 2015 | $15,862,000 | -9.4% | 1,279,198 | 0.0% | 0.01% | -11.1% |
| Q2 2015 | $17,499,000 | +29.4% | 1,279,198 | +13.2% | 0.01% | +28.6% |
| Q1 2015 | $13,519,000 | -18.1% | 1,130,348 | -12.6% | 0.01% | -12.5% |
| Q4 2014 | $16,512,000 | -1.7% | 1,293,029 | +3.2% | 0.01% | -11.1% |
| Q3 2014 | $16,806,000 | -58.2% | 1,252,764 | -50.0% | 0.01% | -18.2% |
| Q2 2014 | $40,214,000 | +43.9% | 2,505,528 | +61.7% | 0.01% | -31.2% |
| Q1 2014 | $27,940,000 | +16.6% | 1,549,665 | 0.0% | 0.02% | +14.3% |
| Q4 2013 | $23,958,000 | +4.0% | 1,549,665 | 0.0% | 0.01% | +7.7% |
| Q3 2013 | $23,044,000 | +14.9% | 1,549,665 | 0.0% | 0.01% | +8.3% |
| Q2 2013 | $20,053,000 | -0.1% | 1,549,665 | +4.9% | 0.01% | -7.7% |
| Q1 2013 | $20,078,000 | +9.3% | 1,477,358 | 0.0% | 0.01% | +8.3% |
| Q3 2012 | $18,364,000 | +35.1% | 1,477,358 | 0.0% | 0.01% | +9.1% |
| Q2 2012 | $13,592,000 | – | 1,477,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |